Anxiousness drug Clonazepam recalled over mislabeling: See lot numbers
An anxiousness drug is being voluntarily recalled over an error that might be “life-threatening”. Endo, Inc. issued a voluntary recall for Clonazepam tablets “as a consequence of potential product carton energy mislabeling.” Within the Meals and Drug Administration’s (FDA)recall alert posted on Nov. 19, the pharmaceutical firm is investigating and increasing its beforehand introduced voluntary recall of Clonazepam.
Read More